gliclazide has been researched along with dinoprost in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Fujino, H; Regan, JW | 1 |
3 other study(ies) available for gliclazide and dinoprost
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Prostaglandin F2alpha amplifies tumor necrosis factor-alpha promoter activity by the FPB prostanoid receptor.
Topics: Animals; Cell Line; Dinoprost; Drug Synergism; Egtazic Acid; Enterotoxins; Enzyme Inhibitors; Genes, Reporter; Glycyrrhetinic Acid; Humans; Indoles; Luciferases; Maleimides; Promoter Regions, Genetic; Protein Isoforms; Protein Kinase C; Receptors, Prostaglandin; rho GTP-Binding Proteins; Sheep; Transfection; Tumor Necrosis Factor-alpha | 2004 |